Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
TAK · NYSE · Pharmaceutical Preparations · Foreign private issuer
Takeda Pharmaceutical (TAK) · oqro.io/stocks/TAK · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$21.43+0.31 (+1.47%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 4, 2026 · Filed Nov 5, 2026
Officer sold ~$1.16M of TAK shares in the open marketSourceInsider trade · Traded Nov 2, 2026 · Filed Nov 4, 2026
Officer sold ~$974K of TAK shares in the open marketSourcePlanned sale · Planned for Nov 1, 2026 · Notice filed Oct 30, 2026
Insider filed to sell about $1.12M of TAK stockSourcePlanned sale · Planned for Nov 1, 2026 · Notice filed Oct 30, 2026
Insider filed to sell about $940K of TAK stockSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Brandes Investment Partners, LP disclosed an increased position in TAK for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Brandes Investment Partners, LP disclosed an increased position in TAK for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 11, 2026
Brandes Investment Partners, LP disclosed a reduced position in TAK for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Brandes Investment Partners, LP disclosed an increased position in TAK for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 13, 2025
Brandes Investment Partners, LP disclosed an increased position in TAK for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Brandes Investment Partners, LP disclosed an increased position in TAK for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 13, 2025
Mondrian Investment Partners LTD disclosed a reduced position in TAK for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 13, 2025
Causeway Capital Management LLC disclosed a reduced position in TAK for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 10, 2025
Brandes Investment Partners, LP disclosed a reduced position in TAK for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 15, 2024
Groupama Asset Managment no longer reported TAK for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Brandes Investment Partners, LP disclosed an increased position in TAK for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 13, 2024
Causeway Capital Management LLC disclosed a reduced position in TAK for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 5, 2024
Mondrian Investment Partners LTD disclosed a reduced position in TAK for Q3 2024Politician trade (House) · Transaction Aug 29, 2023 · Disclosed Sep 5, 2023
Disclosed sale of TAK — reported range $15,001 - $50,000SourcePolitician trade (House) · Transaction Jul 10, 2023 · Disclosed Aug 13, 2023
Disclosed sale of TAK — reported range $15,001 - $50,000SourcePolitician trade (House) · Transaction Feb 27, 2023 · Disclosed Mar 20, 2023
Disclosed purchase of TAK — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Feb 16, 2023 · Disclosed Mar 3, 2023
Disclosed purchase of TAK — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Nov 1, 2022 · Disclosed Dec 6, 2022
Disclosed purchase of TAK — reported range $1,001 - $15,000Source